Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Retinal function in mucolipidosis IV.

F A Abraham, N Brand, M Blumenthal

    Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Mucolipidosis IV (ML IV) causes progressive vision loss. Initial tests showed normal retinal function, but later exams revealed severe retinal damage and vision impairment, similar to tapetoretinal dystrophy.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Determinants for the Access to Follow-Up Rehabilitation Concerning Cardiological Patients after Surgery].

    Die Rehabilitation·2017
    Same author

    Effect of different alcohols on stratum corneum kallikrein 5 and phospholipase A<sub>2</sub> together with epidermal keratinocytes and skin irritation.

    International journal of cosmetic science·2016
    Same author

    Groenouw's macular dystrophy: Histochemistry and ultrastructure of the cornea.

    Documenta ophthalmologica. Advances in ophthalmology·2016
    Same author

    Reliable change assessment with practice effects in sport concussion research: a comment on Hinton-Bayre.

    British journal of sports medicine·2006
    Same author

    Characterization of molecules mediating cell-cell communication in human cardiac valve interstitial cells.

    Cell biochemistry and biophysics·2006
    Same author

    Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events.

    American heart journal·2006
    Same journal

    The risk of retinal vascular events in patients using semaglutide: a scoping review.

    Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde·2026
    Same journal

    Interpreting relative afferent pupillary defect in Leber hereditary optic neuropathy using interocular visual acuity difference.

    Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde·2026
    Same journal

    1 MONTH VS. 3 MONTHS HEAVY SILICONE OIL TAMPONADE IN COMPLEX RHEGMATOGENOUS RETINAL REDETACHMENT.

    Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde·2026
    Same journal

    Visual loss after silicone oil removal - Analysis of a German cohort.

    Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde·2026
    Same journal

    Weekend effect on vitrectomy: Insights from a Nationwide Population-Based Study in Korea.

    Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde·2026
    Same journal

    The Royal College of Ophthalmologists National Ophthalmology Database Age-related Macular Degeneration (AMD) Audit, Report 2: Baseline characteristics, the care pathway and 12-month visual acuity and safety outcomes for 54,882 eyes starting treatment for neovascular AMD.

    Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde·2026
    See all related articles

    Area of Science:

    • Ophthalmology
    • Genetics
    • Neurology

    Background:

    • Mucolipidosis IV (ML IV) is a rare genetic lysosomal storage disorder.
    • Ocular manifestations in ML IV can include corneal clouding and visual pathway abnormalities.